Open Access

Novel compound heterozygous PKHD1 mutations cause autosomal recessive polycystic kidney disease in a Han Chinese family

  • Authors:
    • Jin Wang
    • Dandan Qi
    • Jialiang Yang
    • Dingding Zhang
    • Qingwei Wang
    • Xueming Ju
    • Xiang Zhong
  • View Affiliations

  • Published online on: October 11, 2019     https://doi.org/10.3892/mmr.2019.10738
  • Pages: 5059-5063
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Autosomal recessive polycystic kidney disease (ARPKD) is a hereditary fibrocystic disease that primarily involves the kidneys and hepatobiliary tract. The polycystic kidney and hepatic disease 1 (PKHD1) gene is the only gene implicated in ARPKD. The present study aimed to identify PKHD1 mutations causing ARPKD in a Chinese family. A couple that underwent prenatal genetic diagnosis for ARPKD and their families were recruited for the present study. Genomic DNA was collected from the amniotic fluid of the fetus (proband) and from peripheral blood of all other available family members. Targeted exome sequencing was performed on the couple and the proband, followed by direct Sanger sequencing on other family members and normal controls to confirm candidate pathogenic variants. Two novel compound heterozygous mutations in the PKHD1 gene were identified as causative in the proband, including maternally inherited c.2876C>T (p.Ser959Phe) and paternally inherited c.5772C>A (p.Phe1924Leu). Each mutation was found to co‑segregate with the ARPKD phenotype in the family. Other family members either carried one of the two mutations or lacked both mutations, while the mutations were not found in 576 ethnically matched normal controls. Therefore, two novel compound heterozygous PKHD1 mutations were implicated in causing ARPKD in a Han Chinese family. The results expand the mutation spectrum of PKHD1 that leads to ARPKD, which may improve genetic counseling and prenatal diagnosis for families with ARPKD.
View Figures
View References

Related Articles

Journal Cover

December-2019
Volume 20 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang J, Qi D, Yang J, Zhang D, Wang Q, Ju X and Zhong X: Novel compound heterozygous PKHD1 mutations cause autosomal recessive polycystic kidney disease in a Han Chinese family. Mol Med Rep 20: 5059-5063, 2019.
APA
Wang, J., Qi, D., Yang, J., Zhang, D., Wang, Q., Ju, X., & Zhong, X. (2019). Novel compound heterozygous PKHD1 mutations cause autosomal recessive polycystic kidney disease in a Han Chinese family. Molecular Medicine Reports, 20, 5059-5063. https://doi.org/10.3892/mmr.2019.10738
MLA
Wang, J., Qi, D., Yang, J., Zhang, D., Wang, Q., Ju, X., Zhong, X."Novel compound heterozygous PKHD1 mutations cause autosomal recessive polycystic kidney disease in a Han Chinese family". Molecular Medicine Reports 20.6 (2019): 5059-5063.
Chicago
Wang, J., Qi, D., Yang, J., Zhang, D., Wang, Q., Ju, X., Zhong, X."Novel compound heterozygous PKHD1 mutations cause autosomal recessive polycystic kidney disease in a Han Chinese family". Molecular Medicine Reports 20, no. 6 (2019): 5059-5063. https://doi.org/10.3892/mmr.2019.10738